Hearing News Watch

EDEN PRAIRIE, MINNESOTA – Starkey has a long history of closely partnering with hearing care professionals to provide the best care possible to those with hearing loss. This May, which is the first Better Hearing and Speech Month since the FDA created a new category for Over-the-Counter (OTC) hearing aids, Starkey President and CEO Brandon Sawalich reflected on how hearing healthcare professionals

FARMINGTON, MICHIGAN — Approximately 48 million Americans have some degree of hearing loss and most of those people wait an average of four to five years before seeking help. Proactive hearing checks and interventions, when appropriate, may help reduce one’s risk of dementia and cognitive decline, and provide other benefits. If you haven’t had a recent hearing check, International Hearing

PALM BEACH GARDENS, FLORIDA — Hearing care retailer HearUSA has revealed its plans to launch a series of innovative Hearing Centers of the Future throughout 2023, with the first center opening this month in Palm Beach Gardens, Florida. These state-of-the-art centers are designed to offer clients a novel hearing care experience tailored to their specific needs and lifestyle, aligning with

CHICAGO, ILLINOIS — Hearing care retailer Beltone has announced the expansion of MLM Hearing, LLC Beltone locations into the United States. MLM, which currently operates 29 Beltone Canada locations, has successfully acquired 59 Beltone locations in the U.S., becoming the sole independent distributors of Beltone to operate in both countries. Amir Hadar and Jonathan Weizman, hearing industry veterans and owners

DURHAM, NORTH CAROLINA – MED-EL USA announced today that Austrian cochlear implant pioneers, Dr. Ingeborg Hochmair and Prof. Erwin Hochmair have been granted the 2023 IEEE Alexander Graham Bell Medal for their outstanding contribution to communication and engineering.  The IEEE Alexander Graham Bell Medal is awarded “for exceptional contributions to communications and networking sciences and engineering.” This year’s IEEE Vision, Innovation,

EDEN PRAIRIE, MINNESOTA  – A recent study published in the American Journal of Audiology shows self-reported prevalence of bothersome tinnitus in the U.S. Army is at 17%, substantially higher than that of the general population, which is around 6.6%. In observance of Military Appreciation Month and Better Hearing Month, the most recent episode of Starkey Sound Bites takes a closer look with guest Dr. Brandon Rawlings.

HAUPPAUGE, NEW YORK — Widex USA Inc. has published preliminary results of an ongoing study that validates the use of fractal sound stimulation, specifically new Widex SoundRelax tones, in treating tinnitus and supporting relaxation, concentration and well-being for all Widex wearers. “Widex SoundRelax is the latest evolution in our evidence-based approach to tinnitus treatment, which leverages patented fractal tones algorithmically generated within Widex hearing aids. First introduced for

The British and Irish Hearing Instrument Manufacturer’s Association (BIHIMA) and Alzheimer’s UK are urging people to get their hearing checked regularly to reduce the risk of developing dementia. According to a study by Johns Hopkins University, using hearing instruments is associated with a 32% lower prevalence of dementia. Research indicates that up to 40% of dementia cases could be prevented

RALEIGH, NORTH CAROLINA — Dr. Robert C. Keefer’s new book titled “The Alzheimer’s/Hearing Aid Paradox: In Search of Sanity,” is aimed at helping the 38 million Americans with hearing loss find hearing aids that work. Keefer’s goal is to persuade Congress to mandate Medicare coverage of hearing aids, which he believes would save billions of dollars in Alzheimer’s healthcare costs.

SEATTLE, WASHINGTON — Sound Pharmaceuticals, a biopharmaceutical company, has announced the completion of enrollment in its Phase 3 clinical trial involving SPI-1005 for the treatment of Meniere’s Disease. SPI-1005 is a novel anti-inflammatory drug that has demonstrated improvements in hearing loss and tinnitus in Meniere’s Disease patients in two previous randomized double-blind placebo-controlled trials. The STOPMD-3 trial screened over 250